- Lobbying
- Paul AND Dioguardi
Lobbying Arrangements Results for 'Paul Dioguardi'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to point-of-care systems for value-based care and specialty drug delivery. |
ProciseDX Corporation
|
Forbes-Tate | |||
Details Issues related to infectious disease diagnosis. Issues related to infectious disease diagnosis and value-based care. |
Cytovale, Inc.
|
Forbes-Tate | |||
Details Issues related to kidney health and Medicare Advantage. |
Healthy.io (US), Inc.
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical policy. |
Venatorx Pharmaceuticals
|
Forbes-Tate | |||
Details Issues related to Medicaid enrollment broker issues. |
Conduent Business Services, LLC
|
Forbes-Tate | |||
Details Issues related to biopharmaceutical research, development and commercialization. |
Spero Therapeutics, Inc.
|
Forbes-Tate | |||
Details Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. |
Verde Technologies
|
Forbes-Tate | |||
Details Issues related to regulations that would restrict operations of farm bureau health insurance plans. |
Tennessee Rural Health Improvement Association
|
Forbes-Tate | |||
Details Issues related to Medicaid and COVID-19. |
Molina Healthcare, Inc.
|
Forbes-Tate | |||
Details Issues related to alternative treatments for PTSD and research in treating behavioral health challenges. |
MAPS Public Benefit Corporation
|
Forbes-Tate | |||
Details Issues related to Appropriations, COVID Relief Funds, HRSA. |
Storer Test Express DBA BusTest Express
|
Forbes-Tate | |||
Details Issues related to rare disease, drug development, reimbursement, and market access. |
Ultragenyx Pharmaceutical
|
Forbes-Tate | |||
Details Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and other Infrastructure Packages. |
A Place for Mom, Inc.
|
Forbes-Tate | |||
Details Issues related to Medicare reimbursement, workforce issues and implementation of the No Surprises Act (PL 116-260). Transportation issues regarding medical transport., Issues related to S. 1939 - F... |
Global Medical Response
|
Forbes-Tate | |||
Details Issues related to pharmacy regulation, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency; Issues related to S. 127 - Pharmacy Benefit Manager Transparency A... |
Independent Pharmacy Cooperative
|
Forbes-Tate | |||
Details Issues related to Congressional support for innovation of small technology companies and maintaining pathways antitrust actions by smaller firms. |
AliveCor, Inc.
|
Forbes-Tate | |||
Details Healthcare initiatives related to novel antibody technology platform; Issues related pandemic preparedness. Healthcare initiatives related to novel antibody technology platform. Issues related to p... |
Vir Biotechnology, Inc.
|
Forbes-Tate |